Literature DB >> 21258047

Dynamics of epigenetic modifications in leukemia.

Iris Uribesalgo1, Luciano Di Croce.   

Abstract

Chromatin modifications at both histones and DNA are critical for regulating gene expression. Mis-regulation of such epigenetic marks can lead to pathological states; indeed, cancer affecting the hematopoietic system is frequently linked to epigenetic abnormalities. Here, we discuss the different types of modifications and their general impact on transcription, as well as the polycomb group of proteins, which effect transcriptional repression and are often mis-regulated. Further, we discuss how chromosomal translocations leading to fusion proteins can aberrantly regulate gene transcription through chromatin modifications within the hematopoietic system. PML-RARa, AML1-ETO and MLL-fusions are examples of fusion proteins that mis-regulate epigenetic modifications (either directly or indirectly), which can lead to acute myeloblastic leukemia (AML). An in-depth understanding of the mechanisms behind the mis-regulation of epigenetic modifications that lead to the development and progression of AMLs could be critical for designing effective treatments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258047      PMCID: PMC3080765          DOI: 10.1093/bfgp/elr002

Source DB:  PubMed          Journal:  Brief Funct Genomics        ISSN: 2041-2649            Impact factor:   4.241


  104 in total

Review 1.  Interplay between chromatin remodelers and protein arginine methyltransferases.

Authors:  Sharmistha Pal; Saïd Sif
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

2.  A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.

Authors:  Dorothee Mueller; Christian Bach; Deniz Zeisig; Maria-Paz Garcia-Cuellar; Sara Monroe; Arun Sreekumar; Rong Zhou; Alexey Nesvizhskii; Arul Chinnaiyan; Jay L Hess; Robert K Slany
Journal:  Blood       Date:  2007-09-12       Impact factor: 22.113

3.  A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency.

Authors:  Carl R Walkley; Gemma Haines Olsen; Sebastian Dworkin; Stewart A Fabb; Jeremy Swann; Grant A McArthur; Susan V Westmoreland; Pierre Chambon; David T Scadden; Louise E Purton
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

4.  Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo.

Authors:  Kavitha Sarma; Raphael Margueron; Alexey Ivanov; Vincenzo Pirrotta; Danny Reinberg
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

5.  Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

Authors:  Fumihiko Ishikawa; Shuro Yoshida; Yoriko Saito; Atsushi Hijikata; Hiroshi Kitamura; Satoshi Tanaka; Ryu Nakamura; Toru Tanaka; Hiroko Tomiyama; Noriyuki Saito; Mitsuhiro Fukata; Toshihiro Miyamoto; Bonnie Lyons; Koichi Ohshima; Naoyuki Uchida; Shuichi Taniguchi; Osamu Ohara; Koichi Akashi; Mine Harada; Leonard D Shultz
Journal:  Nat Biotechnol       Date:  2007-10-21       Impact factor: 54.908

6.  Genome-scale DNA methylation maps of pluripotent and differentiated cells.

Authors:  Alexander Meissner; Tarjei S Mikkelsen; Hongcang Gu; Marius Wernig; Jacob Hanna; Andrey Sivachenko; Xiaolan Zhang; Bradley E Bernstein; Chad Nusbaum; David B Jaffe; Andreas Gnirke; Rudolf Jaenisch; Eric S Lander
Journal:  Nature       Date:  2008-07-06       Impact factor: 49.962

7.  Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2.

Authors:  Diego Pasini; Klaus H Hansen; Jesper Christensen; Karl Agger; Paul A C Cloos; Kristian Helin
Journal:  Genes Dev       Date:  2008-05-15       Impact factor: 11.361

8.  Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment.

Authors:  Carl R Walkley; Jeremy M Shea; Natalie A Sims; Louise E Purton; Stuart H Orkin
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

9.  Protein arginine-methyltransferase-dependent oncogenesis.

Authors:  Ngai Cheung; Li Chong Chan; Alex Thompson; Michael L Cleary; Chi Wai Eric So
Journal:  Nat Cell Biol       Date:  2007-09-23       Impact factor: 28.824

10.  Pcl-PRC2 is needed to generate high levels of H3-K27 trimethylation at Polycomb target genes.

Authors:  Maxim Nekrasov; Tetyana Klymenko; Sven Fraterman; Bernadett Papp; Katarzyna Oktaba; Thomas Köcher; Adrian Cohen; Hendrik G Stunnenberg; Matthias Wilm; Jürg Müller
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

View more
  10 in total

Review 1.  Characterising the epigenome as a key component of the fetal exposome in evaluating in utero exposures and childhood cancer risk.

Authors:  Akram Ghantous; Hector Hernandez-Vargas; Graham Byrnes; Terence Dwyer; Zdenko Herceg
Journal:  Mutagenesis       Date:  2015-02-26       Impact factor: 3.000

2.  The HARE-HTH and associated domains: novel modules in the coordination of epigenetic DNA and protein modifications.

Authors:  L Aravind; Lakshminarayan M Iyer
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

Review 3.  Targeting Histone Deacetylases in Diseases: Where Are We?

Authors:  Rosaria Benedetti; Mariarosaria Conte; Lucia Altucci
Journal:  Antioxid Redox Signal       Date:  2014-03-06       Impact factor: 8.401

Review 4.  Chromatin remodeling in cancer: a gateway to regulate gene transcription.

Authors:  Sujit S Nair; Rakesh Kumar
Journal:  Mol Oncol       Date:  2012-10-22       Impact factor: 6.603

5.  HDAC3 is essential for DNA replication in hematopoietic progenitor cells.

Authors:  Alyssa R Summers; Melissa A Fischer; Kristy R Stengel; Yue Zhao; Jonathan F Kaiser; Christina E Wells; Aubrey Hunt; Srividya Bhaskara; Jessica W Luzwick; Shilpa Sampathi; Xi Chen; Mary Ann Thompson; David Cortez; Scott W Hiebert
Journal:  J Clin Invest       Date:  2013-06-10       Impact factor: 14.808

Review 6.  TET proteins: on the frenetic hunt for new cytosine modifications.

Authors:  Benjamin Delatte; François Fuks
Journal:  Brief Funct Genomics       Date:  2013-04-26       Impact factor: 4.241

7.  Inhibition of histone methyltransferase EZH2 depletes leukemia stem cell of mixed lineage leukemia fusion leukemia through upregulation of p16.

Authors:  Koki Ueda; Akihide Yoshimi; Yuki Kagoya; Satoshi Nishikawa; Victor E Marquez; Masahiro Nakagawa; Mineo Kurokawa
Journal:  Cancer Sci       Date:  2014-03-30       Impact factor: 6.716

Review 8.  Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies.

Authors:  Elisabetta Fratta; Barbara Montico; Aurora Rizzo; Francesca Colizzi; Luca Sigalotti; Riccardo Dolcetti
Journal:  Oncotarget       Date:  2016-08-30

Review 9.  Mechanisms of epigenetic regulation of leukemia onset and progression.

Authors:  Panagiotis Ntziachristos; Jasper Mullenders; Thomas Trimarchi; Iannis Aifantis
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

10.  KCTD15 deregulation is associated with alterations of the NF-κB signaling in both pathological and physiological model systems.

Authors:  Giovanni Smaldone; Luigi Coppola; Katia Pane; Monica Franzese; Giuliana Beneduce; Rosanna Parasole; Giuseppe Menna; Luigi Vitagliano; Marco Salvatore; Peppino Mirabelli
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.